Skip to main content


Scientific Name(s): Borago officinalis L.
Common Name(s): Bee fodder, Bee-bread, Borage, Burrage, Common bugloss, Cool tankard, Ox's tongue, Star flower

Medically reviewed by Last updated on Jan 16, 2023.

Clinical Overview


Borage has been used in European herbal medicine since the Middle Ages, alone and in combination with fish oil for the treatment of rheumatoid arthritis, atopic eczema, and osteoporosis, although clinical evidence to support these uses is limited.


Borage seed oil 1 to 3 g/day has been given in clinical trials (1 g/day has been used in children, and up to 3 g/day has been used in adults). The content of gamma-linolenic acid (GLA) is between 20% and 26% of the oil. A 2 g dose of dried herb brewed in 1 cup of boiling water taken 3 times daily has been suggested. Oral doses of 2,000 to 4,000 mg/day (GLA 400 to 1,000 mg) in adults and 1,000 to 2,000 mg/day (GLA 240 to 480 mg) in children with atopic dermatitis have been studied.


Contraindications have not been identified.


Avoid use due to documented adverse effects (pyrrolizidine alkaloids).


None well documented.

Adverse Reactions

Borage oil should be used cautiously in patients with epilepsy. A case report describes the development of temporal lobe and gelastic seizures ultimately progressing to status epilepticus in a healthy 41-year-old woman who consumed borage oil 1,500 to 3,000 mg/day for 1 week. Additionally, borage has been reported as the likely cause of several cases of methemoglobinemia in infants in Europe. In patients with rheumatoid arthritis (RA) taking borage, belching and soft stools occurred. Drug-induced liver toxicity has also been reported with borage.


Because borage seeds contain small amounts of unsaturated pyrrolizidine alkaloids, including amabiline, a hepatotoxin, the German Federal Ministry of Health recommends no more than 10 mcg of unsaturated pyrrolizidine alkaloid consumption each day. Another source recommends no more than 1 mcg/day of unsaturated pyrrolizidine alkaloids. Internal use of whole borage leaf is not recommended.

Scientific Family

  • Boraginaceae (borage)


Borage is an annual plant that grows to about 0.6 m in height. The stem and leaves are covered with coarse, prickly hairs, and the flowers are large, star-shaped, and bright blue with contrasting black anthers. It is native to the Mediterranean region but has been widely naturalized in other areas. The fresh plant has a salty flavor and a cucumber-like odor.1


Borage leaves have been used as a potherb and in European herbal medicine since the Middle Ages, and were mentioned by Pliny (AD 61), Dioscorides (AD 40), and Galen (AD 129). Borage leaves and flowers were added to wine and lemon juice to make the popular English beverages claret cup and cool tankard. The leaves have been used to treat rheumatism, colds, and bronchitis, as well as to increase lactation in women. Infusions of the leaves have been used to induce sweating and diuresis.2


The leaves and flowers contain mucilage, tannin, and a small amount of essential oil. The seed yields a fixed oil with a high content (20% to 26%) of GLA, about twice the content of evening primrose oil, another commercial source.3 The triacylglycerol structure of borage oil has been compared with evening primrose oil and other GLA sources, with GLA attached at position sn-3 in evening primrose oil but at position sn-2 in borage seed oil.4, 5 This difference explains the apparently poorer bioavailability of GLA from borage seed oil compared with evening primrose oil.6 Results of numerous methods for analysis of GLA and other polyunsaturated fatty acids (PUFA) from borage seed oil and leaves have been published.4, 7, 8, 9

Because of the occurrence of toxic pyrrolizidine alkaloids in other members of the Boraginaceae family, borage leaves, seeds, and seed oil have been carefully investigated for their alkaloid content. The unsaturated, potentially toxic alkaloids lycopsamine and amabiline are found in borage leaves, stems, and roots in relatively low concentrations.10 The seeds and flowers contain the saturated pyrrolizidine alkaloid thesinine, along with traces of amabiline, supinine, and other alkaloids. Total alkaloid content of the plant is estimated at less than 0.001%, while mature seeds yield about 0.03% crude alkaloids.11, 12 More sensitive trace analyses are required to measure the safety of borage seed oils. Antioxidant activity of borage has been attributed to rosmarinic acid found in the plant leaves.13

Uses and Pharmacology

The 18-carbon fatty acid linoleic acid is considered essential in human nutrition because it must be obtained from the diet. It is converted by the enzyme delta-6-desaturase to GLA, which is thought to be rate-limiting in the pathway. GLA is further elaborated to the 20-carbon fatty acid dihomogammalinolenic acid (DGLA), a key metabolite for the synthesis of the anti-inflammatory prostaglandins of the 1-series (eg, PGE1) and 15-(S)-hydroxy-8,11,13-eicosatrienoic acid (15HETrE) by different types of cells.14 Theoretically, supplementation with GLA might bypass the rate-limiting step in biosynthesis, providing more of these anti-inflammatory modulators. In addition, pathophysiological conditions alter the ability to convert linoleic acid to GLA.14 Commercial sources of GLA include borage seed oil, evening primrose oil, and black currant seed oil, as well as the oil from the fungus Mucor javanicus.4 Cloning of delta-6-desaturase enzymes into plants that do not typically possess them has been proposed as a means to increase dietary GLA.15

Alcoholic hangover

One study found that GLA from borage significantly reduced the overall severity of alcoholic hangover, as well as headache, laziness, and fatigue, compared with placebo (P < 0.01).76

Antimicrobial effects

In an in vitro study, borage was found to exert amoebicidal activity against Entamoeba histolytica.73 In another study, borage oil was found to exert bactericidal effects against Helicobacter pylori within 60 minutes of application.74


No clinical effect could be demonstrated in a randomized, controlled trial of dietary supplementation versus placebo in asthma patients, despite measurable biochemical differences.5

Dermatological effects

Animal data

In a study of guinea pigs, borage oil given as part of a diet for 2 weeks reversed epidermal hyperproliferation.52

Clinical data

A randomized clinical trial conducted in adults and children favored placebo compared with borage oil for efficacy in atopic eczema.53 Other smaller trials noted a trend toward efficacy, but without reaching clinical importance.54, 55, 56, 57 In a trial designed to estimate the degree of prevention of atopic dermatitis in infants with a familial risk, borage oil supplementation had no effect on dermatitis incidence or serum immunoglobulin E and showed only a trend toward decreased severity of atopic dermatitis.58 In 2013, a Cochrane review identified 8 placebo-controlled randomized clinical trials conducted in adults and children that assessed borage oil for treatment of signs and symptoms of eczema. Meta-analyses could not be conducted on these studies because results were reported in different ways; however, assessments support previous reports of the lack of a significant effect of borage oil on global eczema symptoms. Atopic eczema/dermatitis syndrome has been recommended by an international task force to encompass all forms of eczema, including atopic dermatitis.94

In a study of 26 children ages 2 to 7 years, daily use of undershirts coated with borage oil (GLA 69.3 mg per 100 g of cotton) for 1 month slightly improved or improved erythema (61.6%), itch (65.3%), and dryness (57.7%). It was also shown to reduce transepidermal water loss, suggesting an improvement in the stratum corneum barrier.60 A review of the literature found varying results with the use of borage for atopic dermatitis, with a total of 12 studies of topical or oral borage oil identified. Of these studies, 5 found an effect, 5 found borage oil to be ineffective, and 2 found borage oil to be effective in some patients.61

In healthy female volunteers, a combination of GLA 150 mg in borage oil, catechin 47 mg, and vitamin E 2 mg mixed in a dairy matrix containing probiotics given twice daily was found to improve skin barrier function as early as 16 weeks, with the largest effects after 18 weeks.62 In another study, 45 healthy women were randomized to receive flaxseed 2.2 g/day, borage oil with tocopherol 10 mg/day, or placebo containing 2.2 g/day of medium-chain fatty acids for 12 weeks. Treatment with borage oil was found to exert anti-inflammatory activity as measured by chemically induced inflammation; it was also found to increase skin hydration and reduce transepidermal water loss.63 A small, open experiment in healthy elderly individuals reported improved cutaneous barrier function after 2 months of borage oil supplementation.59


An in vivo experiment with borage oil failed to show an effect on insulin action and was associated with adversely affected lipid levels.71

Effects of gamma linolenic acid

Animal data

Extensive research has demonstrated that dietary supplementation with GLA can alter lipid fatty acid profiles in animal experiments. GLA itself is not always elevated; however, DGLA can be highly elevated by GLA supplementation. Macrophage phospholipids of mice fed borage seed oil showed altered ratios of 20-carbon PUFA.16 DGLA was selectively increased in the same system.17 The particular phospholipid classes altered by GLA supplementation were examined in mice.18 GLA and DGLA in cutaneous phospholipids were markedly increased in guinea pigs after an 8-week feeding experiment, along with the metabolites PGE1 and 15HETrE.19, 20, 21 Borage seed oil and evening primrose oil were equivalent sources of GLA in rats, despite the higher GLA content in borage oil.22 Upon stimulation with zymosan, isolated mouse peritoneal macrophages increased PGE1 synthesis when the mice had been maintained on high-GLA diets.23 Similar changes in hepatocyte PUFA were seen in Atlantic salmon smolts fed diets enriched with borage seed oil.24 Analysis of the interaction of cholesterol metabolism with PUFA metabolism in rats showed that GLA had a smaller hypercholesterolemic effect than alpha-linolenic acid.25 The effects of GLA supplementation in rats administered PUFA differed in immune tissues compared with other tissues.26 Other effects of GLA supplementation in animal models included an increase in Mn-superoxide dismutase in rats,27 decrease in rat liver fatty acid oxidation,28 changes in mouse macrophage–vascular smooth muscle cell interactions, and inhibition of serum cholesterol in aged rats on high-cholesterol diets.29 In a murine model of senile osteoporosis, mice supplemented with GLA-containing diets exhibited improved bone parameters, specifically suggesting a lower osteoclast activity level and, ultimately, a reduction in resorption rate and bone loss.30

Changes in these mediators of inflammation could possibly have an effect on a variety of diseases and conditions; some animal model experiments have been reported. Borage seed oil protected mice from experimental autoimmune encephalomyelitis, with improved clinical, biochemical, and histological parameters.31 Neovascularization of chemically burned rabbit corneas was favorably modulated by dietary GLA.32 The use of enteral and parenteral feeding formulations supplemented with GLA and fish oil was investigated with rat and pig models of acute endotoxin and burn injuries. Rats demonstrated increases in plasma GLA and DGLA,33 but lung microvascular permeability after endotoxin was not improved.34 Pulmonary eicosanoids were altered in endotoxic rats,35 but bacterial killing by macrophages was not changed.36 In pigs, pulmonary surfactant function was not altered despite changes in PUFA composition of the surfactant.37 GLA supplementation in aged rats provided protection against ventricular fibrillation.38 Thus, the link between dietary modulation of PUFA and functional changes remains tenuous in many cases.

Clinical data

Investigations in humans have followed a similar pattern. Borage seed oil increased plasma phospholipid GLA and DGLA levels while augmenting the arterial baroreflex control of vascular resistance in healthy humans, actions that may be useful in the treatment of hypertension.39 Proportions of different phospholipid types were unchanged, but DGLA was increased in platelets when borage seed oil was administered for 42 days.40 Neutrophils from participants whose diets were supplemented with GLA mobilized 3-fold more DGLA after ionophore stimulation compared with controls.41 In older participants, GLA had no effect on natural killer cell activity, while fish oil reduced it by 50%.42 In contrast, T-lymphocyte proliferation was decreased by GLA and fish oil in the same type of population.43 This effect on lymphocytes was reproduced by a second group for GLA in borage seed oil, where increases in plasma GLA and DGLA were observed.44 The release of proinflammatory leukotriene B4 from neutrophils with ionophore stimulation was reduced, while DGLA was elevated in healthy adults. The effects were greater at the higher of the 2 doses.45 In another study of healthy humans, administration of borage oil containing GLA 1.5 g/day for 3 weeks was found to decrease leukotriene synthesis as compared with baseline. After 2 weeks, activity returned to baseline.46 In a study of 50 formerly obese patients, supplementation with GLA (borage oil 5 g/day) was found to reduce weight regain, particularly when completing at least 50 weeks of treatment.47

Hepatoprotective effects

Borage oil was found to exert hepatoprotective effects in rats with alcoholic steatohepatitis. Specifically, rats receiving the oil experienced an improvement in liver morphology, a reduction in triglyceride concentrations, and normalization of serum marker enzyme activities.75


No differences in neurodevelopment were found in a randomized, controlled trial with infants fed supplemented formulas. However, in planned subgroup analysis, male participants fed the long-chain PUFA and borage oil–enriched formula scored higher on growth and neurodevelopment indicators.72


A pilot study of fish oil plus borage seed oil in elderly, osteoporotic women found improved bone density in the treatment arm compared with placebo and improvement after crossover to all treatment in both groups.70

Psychiatric disorders

Clinical data

In a 6-week, randomized, double-blind, parallel study, the effects of Echium amoenum (Boraginaceae) 500 mg compared with placebo were assessed in 44 patients with obsessive-compulsive disorder. By weeks 4 and 6, treatment with borage lowered obsessive, compulsive, and anxiety symptoms.68, 69

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults (2009) states that there is insufficient evidence for a recommendation of use.93

Respiratory distress syndrome

Animal data

In a study of rats, short-term (ie, 4 days) enteral feeding with a GLA and eicosapentaenoic acid (EPA) diet was found to form less inflammatory eicosanoids by alveolar macrophages.36

Clinical data

Compared with controls, a multicenter trial of fish oil and borage seed oil added to enteral feeding mixtures in patients with acute respiratory distress syndrome resulted in improvement in outcomes, with reduced major organ failures, shorter intensive care unit stays, and less ventilator support required.64 On the basis of this trial, Canadian practice guidelines for nutritional support in mechanically ventilated, critically ill patients, made the recommendation that the use of products with fish oils, borage oils, and antioxidants be considered in patients with adult respiratory distress syndrome.65

In a study of 19 pediatric burn patients with acute respiratory distress syndrome, treatment with a specialized enteral product containing EPA, GLA, and antioxidants was found to improve oxygenation and pulmonary compliance compared with baseline after an average of 10.8 ± 0.9 days.66, 67

Rheumatoid arthritis

Clinical data

A 24-week randomized, double-blind, placebo-controlled trial of borage seed oil (GLA 1.4 g/day) in 37 individuals with RA found clinically important reduction in symptoms compared with a cotton seed oil placebo.48 A trial in 56 participants using a higher dose (GLA 2.8 g/day) included a 6-month, double-blind phase and a second 6-month, single-blind trial. Improvement was found in arthritis symptoms for both groups, with the cohort receiving 12 months of GLA supplementation improving throughout both phases.49 No adverse effects were detected in any of these regimens. In an 18-month, randomized, double-blind study, 146 patients with RA received either 3.5 g of omega-3 fatty acids, GLA 1.8 g/day, or combination therapy. No differences were found among treatment groups except for triglycerides. However, when the groups were combined, reductions in total and low-density lipoprotein (LDL) cholesterol and triglyceride levels, an increase in HDL cholesterol levels, and improvement in the atherogenic index were noted.50

A Cochrane review of trials from 1966 to 2000 suggests some benefit from GLA in RA, despite the relative poor quality of the individual studies. There was a trend toward reduction of morning stiffness, joint tenderness, and pain. Sufficient evidence was found to warrant further larger trials to provide optimal dosage, information regarding outcome, and duration of therapy.51

Transcutaneous delivery system

Borage oil has been used experimentally to deliver tamoxifen transcutaneously, with the aim of delivering tamoxifen and GLA through intact breast skin.77


Borage seed oil 1 to 3 g/day has been given in clinical trials (1 g/day has been used in children and up to 3 g/day has been used in adults).44, 53, 78 The content of GLA is 20% and 26% of the oil.48, 49

A 2 g dose of dried herb brewed in 1 cup of boiling water taken 3 times daily has been suggested.79

Oral doses of 2,000 to 4,000 mg/day (GLA 400 to 1,000 mg) in adults and 1,000 to 2,000 mg/day (GLA 240 to 480 mg) in children with atopic dermatitis have been studied.61

Pregnancy / Lactation

Avoid use due to documented adverse effects (pyrrolizidine alkaloids). Avoid use.11, 80, 81, 82, 83


None well documented.

Adverse Reactions

Borage oil should be used cautiously in patients with epilepsy.(86) A case report describes the development of temporal lobe and gelastic seizures ultimately progressing to status epilepticus occurring in a healthy 41-year-old woman who consumed borage oil 1,500 to 3,000 mg/day for 1 week.(87) Additionally, borage has been reported as the likely cause of several cases of methemoglobinemia in infants in Europe.(88) In patients with RA taking borage, belching and soft stools occurred.(89) A systematic review of case studies published through November 2017 identified no reported cases when combining keyword search terms for pyrrolizidine alkaloid-related harm and borage.(96)

The European Association for the Study of the Liver (EASL) clinical practice guideline for drug-induced liver injury (2019) recommends physicians consider herbal and dietary supplements as potential causative agents associated with liver injury (Level 4; Grade C), including borage.(95)


Because borage seeds contain small amounts of unsaturated pyrrolizidine alkaloids, including amabiline, a hepatotoxin, the German Federal Ministry of Health recommends no more than 10 mcg of unsaturated pyrrolizidine alkaloid consumption each day.10, 11, 12, 90, 91, 92 Another source recommends no more than 1 mcg/day of unsaturated pyrrolizidine alkaloid.79 Internal use of whole borage leaf is not recommended.



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

More about borage

Related treatment guides

1. Borago officinalis L. USDA, NRCS. 2013. The PLANTS Database (, 8 July 2013). National Plant Data Team, Greensboro, NC 272401-4901 USA.
2. Awang DVC. Herbal medicine borage. Can Pharm J. 1990;123:121-126.
3. Gibson RA, Lines DR, Neumann MA. Gamma linolenic acid (GLA) content of encapsulated evening primrose oil products. Lipids. 1992;27(1):82-84.1318991
4. Lawson LD, Hughes BG. Triacylglycerol structure of plant and fungal oils containing gamma-linolenic acid. Lipids. 1988;23:313-317.
5. Ziboh VA, Naguwa S, Vang K, et al. Suppression of leukotriene B4 generation by ex-vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: possible implication in asthma. Clin Dev Immunol. 2004;11(1)13-21.15154607
6. Fan YY, Chapkin RS, Ramos KS. Dietary lipid source alters murine macrophage/vascular smooth muscle cell interactions in vitro. J Nutr. 1996;126(9):2083-2088.8814195
7. Wretensjö I, Svensson L, Christie WW. Gas chromatographic−mass spectrometric identification of the fatty acids in borage oil using the picolinyl ester derivatives. J Chromatogr A. 1990;521(1):89-97.
8. Sewón P, Tyystjärvi E. Stearidonic and γ-linolenic acid contents of common borage leaves. Phytochemistry. 1993;33(5):1029-1032.
9. Laakso P, Voutilainen P. Analysis of triacylglycerols by silver-ion high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Lipids. 1996;31(12):1311-1322.8972466
10. Larson KM, Roby MR, Stermitz FR. Unsaturated pyrrolizidines from borage (Borago officinalis), a common garden herb. J Nat Prod. 1984;47(4):747-748.
11. Herrmann M, Joppe H, Schmaus G. Thesinine-4′-O-beta-D-glucoside the first glycosylated plant pyrrolizidine alkaloid from Borago officinalis. Phytochemistry. 2002;60(4):399-402.12031432
12. Dodson CD, Stermitz FR. Pyrrolizidine alkaloids from borage (Borago officinalis) seeds and flowers. J Nat Prod. 1986;49:727-728.
13. Bandoniene D, Murkovic M. The detection of radical scavenging compounds in crude extract of borage (Borago officinalis L.) by using an on-line HPLC-DPPH method. J Biochem Biophys Methods. 2002;53(1-3):45-49.12406585
14. Fan YY, Chapkin RS. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr. 1998;128(9):1411-1414.9732298
15. Palombo JD, DeMichele SJ, Liu JW, Bistrian BR, Huang YS. Comparison of growth and fatty acid metabolism in rats fed diets containing equal levels of gamma-linolenic acid from high gamma-linolenic acid canola oil or borage oil. Lipids. 2000;35(9):975-981.11026618
16. Chapkin RS, Somers SD, Schumacher L, Erickson KL. Fatty acid composition of macrophage phospholipids in mice fed fish or borage oil. Lipids. 1988;23(4):380-383.3398727
17. Chapkin RS, Somers SD, Erickson KL. Dietary manipulation of macrophage phospholipid classes: selective increase of dihomogammalinolenic acid. Lipids. 1988;23(8):766-770.3185109
18. Chapkin RS, Carmichael SL. Effects of dietary n-3 and n-6 polyunsaturated fatty acids on macrophage phospholipid classes and subclasses. Lipids. 1990;25(12):827-834.2093145
19. Miller CC, Ziboh VA. Gammalinolenic acid-enriched diet alters cutaneous eicosanoids. Biochem Biophys Res Commun. 1988;154(3):967-974.2841938
20. Miller CC, Ziboh VA, Wong T, Fletcher MP. Dietary supplementation with oils rich in (n-3) and (n-6) fatty acids influences in vivo levels of epidermal lipoxygenase products in guinea pigs. J Nutr. 1990;120(1):36-44.2106017
21. Miller CC, Tang W, Ziboh VA, Fletcher MP. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. J Invest Dermatol. 1991;96(1):98-103.1987303
22. Raederstorff D, Moser U. Borage or primrose oil added to standardized diets are equivalent sources for gamma-linolenic acid in rats. Lipids. 1992;27(12):1018-1023.1336802
23. Fan YY, Chapkin RS. Mouse peritoneal macrophage prostaglandin E1 synthesis is altered by dietary gamma-linolenic acid. J Nutr. 1992(8);122:1600-1606.1322453
24. Tocher DR, Bell JG, Dick JR, Sargent JR. Fatty acyl desaturation in isolated hepatocytes from Atlantic salmon (Salmo salar): stimulation by dietary borage oil containing gamma-linolenic acid. Lipids. 1997;32(12):1237-1247.
25. Ihara-Watanabe M, Umekawa H, Takahashi T, Furuichi Y. Effects of dietary alpha- or gamma-linolenic acids on levels and fatty acid compositions of serum and hepatic lipids, and activity and mRNA abundance of 3-hydroxy-3-methylglutaryl CoA reductase in rats. Comp Biochem Physiol A Mol Integr Physiol. 1999;122(2):213-220.10327618
26. Kaku S, Yunoki S, Ohkura K, et al. Interactions of dietary fats and proteins on fatty acid composition of immune cells and LTB4 production by peritoneal exudate cells of rats. Biosci Biotechnol Biochem. 2001;65(2):315-321.11302164
27. Phylactos AC, Harbige LS, Crawford MA. Essential fatty acids alter the activity of manganese-superoxide dismutase in rat heart. Lipids. 1994;29(2):111-115.8152344
28. Kumamoto T, Ide T. Comparative effects of alpha- and gamma-linolenic acids on rat liver fatty acid oxidation. Lipids. 1998;33(7):647-654.9688166
29. Fukushima M, Ohhashi T, Ohno S, et al. Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet. Lipids. 2001;36(3):261-266.11337981
30. Wauquier F, Barquissau V, Leotoing L, et al. Borage and fish oils lifelong supplementation decreases inflammation and improves bone health in a murine model of senile osteoporosis. Bone. 2012;50(2):553-561.21664309
31. Harbige LS, Layward L, Morris-Downes MM, Dumonde DC, Amor S. The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol. 2000;122(3):445-452.11122253
32. Ormerod LD, Garsd A, Abelson MB, Kenyon KR. Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali-burned rabbit cornea. Am J Pathol. 1990;137(5):1243-1252.1700621
33. Karlstad MD, DeMichele SJ, Leathem WD, Peterson MB. Effect of intravenous lipid emulsions enriched with gamma-linolenic acid on plasma n-6 fatty acids and prostaglandin biosynthesis after burn and endotoxin injury in rats. Crit Care Med. 1993;21(11):1740-1749.8222692
34. Mancuso P, Whelan J, DeMichele SJ, et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med. 1997;25(3):523-532. 9118672
35. Mancuso P, Whelan J, DeMichele SJ, Snider CC, Guszcza JA, Karlstad MD. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med. 1997;25(7):1198-1206.9233748
36. Palombo JD, DeMichele SJ, Boyce PJ, et al. Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med. 1999;27(9):1908-1915.10507617
37. Murray MJ, Kanazi G, Moukabary K, Tazelaar HD, DeMichele SJ. Effects of eicosapentaenoic and gamma-linolenic acids (dietary lipids) on pulmonary surfactant composition and function during porcine endotoxemia. Chest. 2000;117(6):1720-1727.10858408
38. Charnock JS. Gamma-linolenic acid provides additional protection against ventricular fibrillation in aged rats fed linoleic acid rich diets. Prostaglandins Leukot Essent Fatty Acids. 2000;62(2):129-134.10780878
39. Mills DE, Mah M, Ward RP, Morris BL, Floras JS. Alteration of baroreflex control of forearm vascular resistance by dietary fatty acids. Am J Physiol. 1990;259(6, pt 2):R1164-R1171.2260727
40. Barre DE, Holub BJ. The effect of borage oil consumption on the composition of individual phospholipids in human platelets. Lipids. 1992;27(5):315-320.1328794
41. Chilton-Lopez, Surette ME, Swan DD, Fonteh AN, Johnson MM, Chilton FH. Metabolism of gammalinolenic acid in human neutrophils. J Immunol. 1996;156(8):2941-2947.8609415
42. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with eicosapentenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged > 55 y. Am J Clin Nutr. 2001;73(3):539-548.11237929
43. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr. 2001;131(7):1918-1927.11435508
44. Rossetti RG, Seiler CM, DeLuca P, Laposata M, Zurier RB. Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation. J Leukoc Biol. 1997;62(4):438-443.9335312
45. Ziboh VA, Fletcher MP. Dose-response effects of dietary gamma-linolenic acid-enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4. Am J Clin Nutr. 1992;55(1):39-45.1309474
46. Chilton FH, Rudel LL, Parks JS, Arm JP, Seeds MC. Mechanisms by which botanical lipids affect inflammatory disorders. Am J Clin Nutr. 2008;87(2):498S-503S.18258646
47. Schirmer MA, Phinney SD. Gamma-linoleate reduces weight regain in formerly obese humans. J Nutr. 2007;137(6):1430-1435.17513402
48. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med. 1993;119(9):867-873.8214997
49. Zurier RB, Rossetti RG, Jacobson EW, et al. Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum. 1996;39(11):1808-1817.8912502
50. Olendzki BC, Leung K, Van Buskirk S, Reed G, Zurier RB. Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids. Evid Based Complement Alternat Med. 2011;2011:827286.2200725710.1155/2011/827286
51. Little C, Parsons T. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2001;(1):CD002948.12368400
52. Chung S, Kong S, Seong K, Cho Y. Gamma-linolenic acid in borage oil reverses epidermal hyperproliferation in guinea pigs. J Nutr. 2002;132(10):3090-3097.
53. Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ. 2003;327(7428):1385.14670885
54. Henz BM, Jablonska S, Van de Kerkhof PC, et al. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol. 1999;140(4):685-688.10233322
55. Kapoor R, Klimaszewski A. Efficacy of borage oil in patients with atopic eczema. Br J Dermatol. 2000;143(1):200-201.10886164
56. Henz BM. Efficacy of borage oil in patients with atopic eczema. Br J Dermatol. 2000;143(1):201.
57. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000;4(37):1-191.11134919
58. van Gool CJ, Thijs C, Henquet CJ, et al. Gamma-linolenic acid supplementation for prophylaxis of atopic dermatitis—a randomized controlled trial in infants at high familial risk. Am J Clin Nutr. 2003;77(4):943-951.12663296
59. Brosche T, Platt D. Effect of borage oil consumption on fatty acid metabolism, transepidermal water loss and skin parameters in elderly people. Arch Gerontol Geriatr. 2000;30(2):139-150.15374040
60. Kanehara S, Ohtani T, Uede K, Furukawa F. Undershirts coated with borage oil alleviate the symptoms of atopic dermatitis in children. Eur J Dermatol. 2007;17(5):448-449.17673396
61. Foster RH, Hardy G, Alany RG. Borage oil in the treatment of atopic dermatitis. Nutrition. 2010;26(7-8):708-718.20579590
62. Puch F, Samson-Villeger S, Guyonnet D, et al. Consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function. Exp Dermatol. 2008;17(8):668-674.18318715
63. De Spirt S, Stahl W, Tronnier H, et al. Intervention with flaxseed and borage oil supplements modulates skin condition in women. Br J Nutr. 2009;101(3):440-445.18761778
64. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med. 1999;27(8):1409-1420.10470743
65. Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27(5):355-374.12971736
66. Mayes T, Gottschlich MM, Kagan RJ. An evaluation of the safety and efficacy of an anti-inflammatory, pulmonary enteral formula in the treatment of pediatric burn patients with respiratory failure. J Burn Care Res. 2008;29(1):82-88.18182902
67. Hamilton LA, Trobaugh KA. Acute respiratory distress syndrome: use of specialized nutrients in pediatric patients and infants. Nutr Clin Pract. 2011;26(1):26-30.21266694
68. Sayyah M, Boostani H, Parkseresht S, Malaireri A. Efficacy of aqueous extract of Echium ameonum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1513-1516.19737592
69. Sarris J, Camfield D, Berk M. Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review. J Affect Disord. 2012;138(3):213-221.21620478
70. Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH. Calcium, gamma-linolenic acid and eicosapentenoic acid supplementation in senile osteoporosis. Aging (Milano). 1998;10(5):385-394.9932142
71. Simoncikova P, Wein S, Gasperikova D, et al. Comparison of the extrapancreatic action of gamma-linolenic acid and n-3 PUFAs in the high fat diet-induced insulin resistance. Endocr Regul. 2002;36(4):143-149.12466014
72. Fewtrell MS, Abbott RA, Kennedy K, et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr. 2004;144(4):471-479.15069395
73. Leos-Rivas C, Verde-Star MJ, Torres, LO. In vitro amoebicidal activity of borage (Borago officinalis) extract on Entamoeba histolytica. J Med Food. 2011;14(7-8):866-869.21476887
74. O'Mahony R, Al-Khtheeri H, Weerasekera D, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005;11(47):7499-7507.16437723
75. Lukivskaya OY, Martua E, Sadovnichy V, Kirko S, Buko VU. Reversal of experimental ethanol-induced liver steatosis by borage oil. Phytother Res. 2012;26(11):1626-1631.22359349
76. Pittler MH, Verster JC, Ernst E. Interventions for preventing or treating alcohol hangover: systematic review of randomised controlled trials. BMJ. 2005;331(7531):1515-1517.16373736
77. Heard CM, Gallagher SJ, Congiatu C, et al. Preferential pi-pi complexation between tamoxifen and borage oil/gamma linolenic acid: transcutaneous delivery and NMR spectral modulation. Int J Pharm. 2005;302(1-2):47-55.16115741
78. Rosenstein ED, Kushner LJ, Kramer N, Kazandjian G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids. 2003;68(3):213-218.12591005
79. vanWyk BE, Wink M. Medicinal Plants of the World. 1st ed. Portland, OR: Timber Press; 2004:68.
80. Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Philadelphia, PA: Hanley & Belfus; 2002.
81. Brinker FJ. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications; 1998.
82. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: Pharmaceutical Press; 1996.
83. Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG. 2002;109(3):227-235.11950176
86. Spinella M. Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav. 2001;2(6):524-532.12609386
87. Al-Khamees WA, Schwartz MD, Alrashdi S, Algren AD, Morgan BW. Status epilepticus associated with borage oil ingestion. J Med Toxicol. 2011;7(2):154-157.21387119
88. Martinez A, Sanchez-Valverde F, Gil F, et al. Methemoglobinemia induced by vegetable intake in infants in northern Spain. J Pediatr Gastroenterol Nutr. 2013;56(5):573-577.
89. Macfarlane GJ, El-Metwally A, DeSilva V, et al. Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review. Rheumatology. 2011;50(9):1672-1683.21652584
90. Awang DV. Tyler’s Herbs of Choice: The Therapeutic Use of Phytomedicinals. 3rd ed. Boca Raton, FL: CRC Press; 2009:159.
91. Langer T, Franz C. Determination of pyrrolizidine alkaloids in commercial samples of borage seed oil products by GC-MS. Sci Pharm. 1997;65:321-328.
92. Mierendorff HJ. Determination of pyrrolizidine alkaloids by thin-layer chromatography in the oil of seeds of Borago off. L. [in German]. Fett/Lipid. 1995;97(1):33-37.
93. Ravindran AV, Lam RW, Filteau MJ, et al; Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord. 2009;117(suppl 1):S54-S64.19666194
94. Bamford JT, Ray S, Musekiwa A, van Gool C, Humphreys R, Ernst E. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst Rev. 2013;4CD004416.23633319
95. European Association for the Study of the Liver. Electronic address:; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative:. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70(6):1222-1261.30926241
96. Avila C, Breakspear I, Hawrelak J, Salmond S, Evans S. A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale). Fitoterapia. 2020;142:104519.32105669

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.